BB's Stock Haven

[Icewood314]

$RSII ~ Rising India Inc (OTCMKTS:RSII) Advances Cannophen™


Rising India Inc (OTCMKTS:RSII) reported that its Ohio laboratory is close to completion at par with the Ohio state issuing MMJ licenses. Arthur Hall, the COO, expressed that now that Ohio is starting to issue licenses, they intend on being fully functional in their medical marijuana lab, which will emphasis on research, development, manufacturing and licensing of innovative offerings in the Cannabis space committed to serving patients with the best standards.

The details

The COO of Rising India reported that they are also excited to state that comprised in a line of medicinal cannabis offerings, the firm is launching Cannophen™, a revolutionary offering they have been advancing for some time now. Cannophen™ marks as an oral capsule with lab measured metered dosing that can be mixed in exacting ratios of CBD, strain specific terpenes and THC. It is fast acting and easily digestible intended for patients that don’t want to vape/smoke or use off-tasting tinctures.

This enables patients to take their drug by swallowing a capsule. They are also delighted to report a new MMJ form of the TSW pain cream having Cannabidiol. Hall added that there has never been any ideal way to dose with the aforementioned methods. They have advanced Cannophen™ utilizing the strictest control and quality methods and standards established in the pharmacy compounding industry utilizing veteran pharmacists and experienced chemists. Also, Rising Biosciences is approaching completion on its FDA assessment of the TSW pain cream products.

The COO of Rising India expressed that they have also had remarkable feedback from those that obtained study tasters of the Clinical Strength Scar Peptide Serum and they now move into the subsequent phase of production. The company together with PAO Group Inc. is assisting lower the grip of opioids on America by focusing its efforts on the responsible cannabis use.

http://mmjreporter.com/rising-india-inc-otcmktsrsii-advances-cannophen-34664.html